NCT04927338View on ClinicalTrials.gov

Study of Bacopa in Gulf War Illness Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Gulf War Illness
Interventions
DIETARY_SUPPLEMENT

BacoMind® (Bacopa monnieri standardized extract)

BacoMind® (Bacopa monnieri standardized extract) 300 mg daily capsule.

DRUG

Placebo

Daily placebo capsule identical in size, color, and shape to that of the Bacopa capsules.

Trial Locations (1)

33314

RECRUITING

Nova Southeastern University, Davie

All Listed Sponsors
collaborator

RTI International

OTHER

collaborator

Boston University

OTHER

lead

Nova Southeastern University

OTHER